← back to search

Jin‐Fei Lin

Sun Yat-sen University · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include RNA modifications and cancer, Cancer, Hypoxia, and Metabolism, Cancer-related molecular mechanisms research, and Ferroptosis and cancer prognosis.
h-index
16
citations
2,204
works
39
NIH funding
primary concept
email

Recent publications

PANoptosis in cancer: bridging molecular mechanisms to therapeutic innovations
Cellular and Molecular Immunology 2025cited by 26position: firstdoi
WTAP weakens oxaliplatin chemosensitivity of colorectal cancer by preventing PANoptosis
Cancer Letters 2024cited by 28position: middledoi
FTO up‐regulation induced by MYC suppresses tumour progression in Epstein‒Barr virus‐associated gastric cancer
Clinical and Translational Medicine 2023cited by 24position: middledoi
Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis
Signal Transduction and Targeted Therapy 2022cited by 305position: firstdoi
CPT1A promotes anoikis resistance in esophageal squamous cell carcinoma via redox homeostasis
Redox Biology 2022cited by 66position: middledoi
Arginine methylation of MTHFD1 by PRMT5 enhances anoikis resistance and cancer metastasis
Oncogene 2022cited by 43position: middledoi
FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis
Oncogene 2021cited by 169position: middledoi
LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer
Cancer Communications 2020cited by 714position: middledoi
NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications
Signal Transduction and Targeted Therapy 2020cited by 529position: middledoi
VDR–SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment
Signal Transduction and Targeted Therapy 2020cited by 68position: middledoi
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
Molecular Cancer 2019cited by 868position: middledoi
Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer
Journal of Experimental & Clinical Cancer Research 2019cited by 70position: middledoi
Profiling the human immune response to Mycobacterium tuberculosis by human cytokine array
Tuberculosis 2016cited by 33position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Huai‐Qiang Ju · Sun Yat-sen University10 papers (2019–2025)Rui‐Hua Xu · Henan Medical University9 papers (2019–2024)Ting Li · Nanjing Medical University6 papers (2019–2024)Yue‐Tao Tan · Sun Yat-sen University5 papers (2020–2025)Zhao-Lei Zeng · Sun Yat-sen University5 papers (2019–2023)Dan Xie · Capital Medical University4 papers (2019–2020)Qi‐Nian Wu · Sun Yat-sen University4 papers (2019–2022)Zexian Liu · Sun Yat-sen University4 papers (2019–2022)Peishan Hu · Sun Yat-sen University3 papers (2019–2022)Kai Yu · Sun Yat-sen University3 papers (2021–2022)Yun‐Xin Lu · Sun Yat-sen University3 papers (2020–2022)Zhan‐Hong Chen · South China Agricultural University3 papers (2019–2020)Qi Zhao · Academy of Medical Sciences2 papers (2020–2021)Junzhong Lin · Sun Yat-sen University2 papers (2021–2022)Dan‐Yun Ruan · Sun Yat-sen University2 papers (2021–2023)Feng Wang · Sun Yat-sen University2 papers (2019–2019)Kun Liao · Sun Yat-sen University2 papers (2022–2022)Heng‐Ying Pu · Sun Yat-sen University2 papers (2020–2022)Qi Meng · Sun Yat-sen University2 papers (2022–2023)Miao‐Zhen Qiu · Sun Yat-sen University2 papers (2020–2022)